Toshihiko Kuroda

Harvard University — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

20h-index2.2kcitations89works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(37), Viral Infectious Diseases and Gene Expression in Insects(26), Cancer Research and Treatments(19), Herpesvirus Infections and Treatments(14), CAR-T cell therapy research(6)

Publications88 total

Supplementary Figure 2 from Human Glioblastoma–Derived Cancer Stem Cells: Establishment of Invasive Glioma Models and Treatment with Oncolytic Herpes Simplex Virus Vectors
2023Open Access
Supplementary Figure 3 from Human Glioblastoma–Derived Cancer Stem Cells: Establishment of Invasive Glioma Models and Treatment with Oncolytic Herpes Simplex Virus Vectors
2023Open Access
Data from Triple Gene-Deleted Oncolytic Herpes Simplex Virus Vector Double-Armed with Interleukin 18 and Soluble B7-1 Constructed by Bacterial Artificial Chromosome–Mediated System
2023Open Access
Data from Human Glioblastoma–Derived Cancer Stem Cells: Establishment of Invasive Glioma Models and Treatment with Oncolytic Herpes Simplex Virus Vectors
2023Open Access
Supplementary Table 1 from Human Glioblastoma–Derived Cancer Stem Cells: Establishment of Invasive Glioma Models and Treatment with Oncolytic Herpes Simplex Virus Vectors
2023Open Access
Supplementary Figure 3 from Human Glioblastoma–Derived Cancer Stem Cells: Establishment of Invasive Glioma Models and Treatment with Oncolytic Herpes Simplex Virus Vectors
2023Open Access
Supplementary Figure 4 from Human Glioblastoma–Derived Cancer Stem Cells: Establishment of Invasive Glioma Models and Treatment with Oncolytic Herpes Simplex Virus Vectors
2023Open Access
Supplementary Figures S1 & S2, Table S1 from Effective Treatment of Tumors with Strong β-Catenin/T-Cell Factor Activity by Transcriptionally Targeted Oncolytic Herpes Simplex Virus Vector
2023Open Access
Data from Triple Gene-Deleted Oncolytic Herpes Simplex Virus Vector Double-Armed with Interleukin 18 and Soluble B7-1 Constructed by Bacterial Artificial Chromosome–Mediated System
2023Open Access
Supplementary Figure 1 from Human Glioblastoma–Derived Cancer Stem Cells: Establishment of Invasive Glioma Models and Treatment with Oncolytic Herpes Simplex Virus Vectors
2023Open Access
Supplementary Figure 2 from Human Glioblastoma–Derived Cancer Stem Cells: Establishment of Invasive Glioma Models and Treatment with Oncolytic Herpes Simplex Virus Vectors
2023Open Access
Data from Human Glioblastoma–Derived Cancer Stem Cells: Establishment of Invasive Glioma Models and Treatment with Oncolytic Herpes Simplex Virus Vectors
2023Open Access
Supplementary Table 1 from Human Glioblastoma–Derived Cancer Stem Cells: Establishment of Invasive Glioma Models and Treatment with Oncolytic Herpes Simplex Virus Vectors
2023Open Access
Supplementary Figures S1 & S2, Table S1 from Effective Treatment of Tumors with Strong β-Catenin/T-Cell Factor Activity by Transcriptionally Targeted Oncolytic Herpes Simplex Virus Vector
2023Open Access
Supplementary Figures 1-4 from Triple Gene-Deleted Oncolytic Herpes Simplex Virus Vector Double-Armed with Interleukin 18 and Soluble B7-1 Constructed by Bacterial Artificial Chromosome–Mediated System
2023Open Access
Supplementary Figures 1-4 from Triple Gene-Deleted Oncolytic Herpes Simplex Virus Vector Double-Armed with Interleukin 18 and Soluble B7-1 Constructed by Bacterial Artificial Chromosome–Mediated System
2023Open Access
Supplementary Legends for Figures 1- 4, Table 1 from Human Glioblastoma–Derived Cancer Stem Cells: Establishment of Invasive Glioma Models and Treatment with Oncolytic Herpes Simplex Virus Vectors
2023Open Access
Supplementary Legends for Figures 1- 4, Table 1 from Human Glioblastoma–Derived Cancer Stem Cells: Establishment of Invasive Glioma Models and Treatment with Oncolytic Herpes Simplex Virus Vectors
2023Open Access
Supplementary Figure 1 from Human Glioblastoma–Derived Cancer Stem Cells: Establishment of Invasive Glioma Models and Treatment with Oncolytic Herpes Simplex Virus Vectors
2023Open Access
Data from Effective Treatment of Tumors with Strong β-Catenin/T-Cell Factor Activity by Transcriptionally Targeted Oncolytic Herpes Simplex Virus Vector
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Robert L. Martuza(11), Samuel D. Rabkin(9), Hiroaki Wakimoto(6), Ta‐Chiang Liu(5), Deva S. Jeyaretna(5), Tomoki Todo(5), Bryan C. Fuchs(4), Michael Lanuti(4), Kenneth K. Tanabe(4), Khalid Shah(4), Tetsu Akiyama(4), Hiroshi Fukuhara(4), Hideo Akiyama(4), Hiroshi Yasuhara(4), Anthony D. Schmitt(3), Santosh Kesari(3), Christopher J. Farrell(3), William T. Curry(3), Cécile Zaupa(3), Manish K. Aghi(3)